Bio-Rad(BIO_B) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Bio-Rad Reports First-Quarter 2024 Financial Results First-quarter 2024 total net sales were $610.8 million, a decrease of 9.8 percent compared to $676.8 million reported for the first quarter of 2023. On a currency-neutral basis, quarterly sales decreased 9.6 percent compared to the same period in 2023. Clinical Diagnostics segment net sales for the first quarter were $368.6 million, an increase of 4.7 percent compared to the same period in 2023. On a currency-neutral basis, net sales increase ...